Insights — 01

Editorial perspective
from inside the platform.

Long-form writing from ZMD Group on physician-led healthcare, multi-specialty integration, M&A, regenerative medicine, and the operating model of a research-integrated platform.

Editorial photograph for "Selling Your Medical Practice: A Physician-First Process Brief"
Practice Sale·8 min

Selling Your Medical Practice: A Physician-First Process Brief

A physician-first practice sale is a confidential, founder-led conversation — not a broker-run auction. A typical ZMD Group process moves from initial conversation to close in roughly four to six months.

Marques Kernan, MBA · April 5, 2026

Editorial photograph for "Multi-Specialty Integration: The Operating Model Most Platforms Skip"
Integrated Care·6 min

Multi-Specialty Integration: The Operating Model Most Platforms Skip

Genuine multi-specialty integration is an operating model, not a marketing line. The clinical handoff design, shared standards, and data architecture behind ZMD Group.

Dr. Hootan Zandifar, MD · March 22, 2026

Editorial photograph for "Regenerative Medicine and Longevity: What the Evidence Actually Supports"
Regenerative + Wellness·7 min

Regenerative Medicine and Longevity: What the Evidence Actually Supports

An honest editorial look at the regenerative medicine and longevity field — what the peer-reviewed evidence supports, what is marketing, and where ZMD Group invests.

Editorial · March 14, 2026

Editorial photograph for "Aesthetic Medicine at the Luxury Standard: Beyond the LaserAway Model"
Aesthetic Medicine·6 min

Aesthetic Medicine at the Luxury Standard: Beyond the LaserAway Model

Luxury-standard aesthetic medicine differs from the chain-clinic model on four axes: who performs, how devices are selected, how outcomes are tracked, and how the experience is governed.

Dr. Hootan Zandifar, MD · March 1, 2026

Editorial photograph for "Why Boston: The Clinical Research Anchor Behind ZMD Group's Second Region"
Boston Expansion·5 min

Why Boston: The Clinical Research Anchor Behind ZMD Group's Second Region

Boston is ZMD Group's designated second region. The reason is structural: the country's deepest research-hospital ecosystem is the right anchor for our research arm.

Marques Kernan, MBA · February 21, 2026

Editorial photograph for "The Research Arm as a Structural Moat"
Research Arm·5 min

The Research Arm as a Structural Moat

Why ZMD Group's integrated clinical research division is a structural competitive advantage rather than a marketing line — and why most platforms cannot replicate it.

Editorial · February 12, 2026

Editorial photograph for "Founder Note: Why I Started ZMD Group"
Founder Narrative·6 min

Founder Note: Why I Started ZMD Group

Founder note from Dr. Hootan Zandifar, MD on why he started ZMD Group: a physician-led, multi-specialty, research-integrated platform built at the luxury standard.

Dr. Hootan Zandifar, MD · January 30, 2026

Editorial photograph for "The ZMD Group M&A Playbook: How a Physician-Led Acquisition Actually Runs"
M&A Process·8 min

The ZMD Group M&A Playbook: How a Physician-Led Acquisition Actually Runs

A transparent walk-through of ZMD Group's M&A playbook: from initial conversation through indicative valuation, diligence, structure, close, and 100-day integration.

Marques Kernan, MBA · January 18, 2026

Editorial photograph for "Building a Career Inside a Physician-Led Platform"
Careers·6 min

Building a Career Inside a Physician-Led Platform

What it actually means to build a career inside a physician-led healthcare platform — clinical autonomy, equity, governance, and the kind of work that compounds.

Editorial · January 9, 2026